• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒(COVID-19)德尔塔及德尔塔plus变异株刺突蛋白的潜在抑制剂:印度东北部药用植物的计算机模拟研究

Potential inhibitors of SARS-CoV-2 (COVID 19) spike protein of the delta and delta plus variant: In silico studies of medicinal plants of North-East India.

作者信息

Solo Peter, Doss M Arockia

机构信息

Department of Chemistry, St. Joseph's College (Autonomous), Jakhama, India.

Department of Chemistry, St. Joseph University, Dimapur, India.

出版信息

Curr Res Pharmacol Drug Discov. 2021;2:100065. doi: 10.1016/j.crphar.2021.100065. Epub 2021 Oct 22.

DOI:10.1016/j.crphar.2021.100065
PMID:34870160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8530778/
Abstract

Phytochemicals of 38 Medicinal plants of North-East India, with anti-viral, anti-oxidant or anti-bacterial properties were screened for properties of drug likeness. 231 phytochemicals were screened with LIPINSKI rule of five to obtain 131 candidates, which were further screened with SWISS-ADME, to obtain 50 phytochemicals. These phytochemicals were docked with the spike protein of the Delta variant (B.1.617.2) and Delta-Plus (AY.1) variant of SARS-CoV-2 using Autodock Vina and MOE 09. The target proteins were constructed by homology modeling using Swiss-Model. Hydroxychloroquine, taken as a standard in docking analysis, exhibited a binding energy of -6.5 ​kcal/mol and -6.1 ​kcal/mol with respect to the Delta variant and Delta-Plus variant respectively. Among the 50 docked results most flavones showed very good docking scores. 3,5,8-Trimethoxy-6,7,4,5-bis(methylenedioxy)flavone, a Poly-Methoxyflavone, produced a highest docking score of -8.7 ​kcal/mol with respect to both the spike protein targets. Poly-Methoxyflavones and Poly-Ethoxyflavones exhibited good binding affinity for the target spike protein of SARS-CoV-2, and can be potential anti-viral drug candidates against the existing Delta variant of the SARS-CoV-2.

摘要

对印度东北部38种具有抗病毒、抗氧化或抗菌特性的药用植物的植物化学物质进行了类药性质筛选。使用Lipinski五规则对231种植物化学物质进行筛选,得到131个候选物,再用SWISS-ADME进一步筛选,得到50种植物化学物质。使用Autodock Vina和MOE 09将这些植物化学物质与SARS-CoV-2的Delta变种(B.1.617.2)和Delta Plus变种(AY.1)的刺突蛋白进行对接。目标蛋白通过使用Swiss-Model的同源建模构建。在对接分析中作为标准的羟氯喹,与Delta变种和Delta Plus变种的结合能分别为-6.5千卡/摩尔和-6.1千卡/摩尔。在50个对接结果中,大多数黄酮类化合物显示出非常好的对接分数。3,5,8-三甲氧基-6,7,4,5-双(亚甲二氧基)黄酮,一种聚甲氧基黄酮,相对于两个刺突蛋白靶点产生了最高对接分数-8.7千卡/摩尔。聚甲氧基黄酮和聚乙氧基黄酮对SARS-CoV-2的目标刺突蛋白表现出良好的结合亲和力,并且可能是针对现有SARS-CoV-2 Delta变种的潜在抗病毒药物候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/efddd83b4db4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/fdf82fba702c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/bc80d8e0c9a1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/e3022c5789fc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/5d169350982b/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/ebd0f8b81713/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/1029fa98a9e8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/efddd83b4db4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/fdf82fba702c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/bc80d8e0c9a1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/e3022c5789fc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/5d169350982b/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/ebd0f8b81713/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/1029fa98a9e8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83db/8663937/efddd83b4db4/gr6.jpg

相似文献

1
Potential inhibitors of SARS-CoV-2 (COVID 19) spike protein of the delta and delta plus variant: In silico studies of medicinal plants of North-East India.新冠病毒(COVID-19)德尔塔及德尔塔plus变异株刺突蛋白的潜在抑制剂:印度东北部药用植物的计算机模拟研究
Curr Res Pharmacol Drug Discov. 2021;2:100065. doi: 10.1016/j.crphar.2021.100065. Epub 2021 Oct 22.
2
Virtual Screening of Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme.基于 SARS-CoV-2 主蛋白酶的虚拟筛选潜在抑制剂的植物化学成分
Molecules. 2022 Nov 21;27(22):8103. doi: 10.3390/molecules27228103.
3
Exploring the inhibitory potential of and phytoconstituents against the Spike glycoprotein receptor binding domain of SARS-CoV-2 Delta (B.1.617.2) variant and the main protease (M) as therapeutic candidates, using Molecular docking, DFT, and ADME/Tox studies.利用分子对接、密度泛函理论(DFT)和药物代谢动力学/毒理学(ADME/Tox)研究,探索[具体物质]植物成分对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)Delta(B.1.617.2)变体的刺突糖蛋白受体结合结构域和主要蛋白酶(M)的抑制潜力,以作为治疗候选物。
J Mol Struct. 2022 Sep 5;1263:133032. doi: 10.1016/j.molstruc.2022.133032. Epub 2022 Apr 9.
4
Multi-target potential of Indian phytochemicals against SARS-CoV-2: A docking, molecular dynamics and MM-GBSA approach extended to Omicron B.1.1.529.印度植物化学物质对 SARS-CoV-2 的多靶点潜力:一种对接、分子动力学和 MM-GBSA 方法,扩展到 Omicron B.1.1.529.
J Infect Public Health. 2022 Jun;15(6):662-669. doi: 10.1016/j.jiph.2022.05.002. Epub 2022 May 13.
5
Silybin B and Cianidanol Inhibit M and Spike Protein of SARS-CoV-2: Evidence from in silico Molecular Docking Studies.水飞蓟宾B和奇尼丹醇抑制新型冠状病毒的M蛋白和刺突蛋白:基于计算机模拟分子对接研究的证据
Curr Pharm Des. 2021;27(32):3476-3489. doi: 10.2174/1381612826666201210122726.
6
Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an study for drug development.用天然植物化学物质靶向 COVID-19 的 SARS-CoV-2 刺突蛋白:一项药物研发研究。
J Biomol Struct Dyn. 2021 Oct;39(16):6306-6316. doi: 10.1080/07391102.2020.1796811. Epub 2020 Jul 22.
7
Insights on the interaction of SARS-CoV-2 variant B.1.617.2 with antibody CR3022 and analysis of antibody resistance.严重急性呼吸综合征冠状病毒2变异株B.1.617.2与抗体CR3022的相互作用见解及抗体抗性分析
J Genet Eng Biotechnol. 2023 Mar 20;21(1):35. doi: 10.1186/s43141-023-00492-y.
8
Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.利用分子对接方法从美国食品药品监督管理局(FDA)批准的抗病毒药物中进行双重抑制剂对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白和主要蛋白酶的计算筛选。
Acta Virol. 2021;65(2):160-172. doi: 10.4149/av_2021_208.
9
validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.验证香豆素衍生物作为潜在抑制剂对 SARS-CoV-2 的主要蛋白酶、NSP10/NSP16-甲基转移酶、磷酸酶和内切核糖核酸酶的抑制作用。
J Biomol Struct Dyn. 2021 Nov;39(18):7306-7321. doi: 10.1080/07391102.2020.1808075. Epub 2020 Aug 24.
10
Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening.通过虚拟筛选探索对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的主要蛋白酶、刺突糖蛋白、RNA依赖性RNA聚合酶和非结构蛋白具有抑制活性的传统药用植物的植物化学物质。
Front Pharmacol. 2021 Jul 8;12:667704. doi: 10.3389/fphar.2021.667704. eCollection 2021.

引用本文的文献

1
Investigating new drugs from marine seaweed metabolites for cervical cancer therapy by molecular dynamic modeling approach.通过分子动力学建模方法研究来自海洋海藻代谢物的新型宫颈癌治疗药物。
Sci Rep. 2025 Jan 31;15(1):3866. doi: 10.1038/s41598-024-82043-0.
2
Generative adversarial network (GAN) model-based design of potent SARS-CoV-2 M inhibitors using the electron density of ligands and 3D binding pockets: insights from molecular docking, dynamics simulation, and MM-GBSA analysis.基于生成对抗网络(GAN)模型,利用配体电子密度和三维结合口袋设计强效严重急性呼吸综合征冠状病毒2(SARS-CoV-2)M蛋白抑制剂:分子对接、动力学模拟和MM-GBSA分析的见解
Mol Divers. 2024 Nov 30. doi: 10.1007/s11030-024-11047-9.
3

本文引用的文献

1
The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins.植物化学物质通过靶向宿主和病毒蛋白对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抑制的双重作用。
J Tradit Complement Med. 2022 Jan;12(1):90-99. doi: 10.1016/j.jtcme.2021.09.001. Epub 2021 Sep 8.
2
Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants.模拟构象状态动力学及其在 SARS-CoV-2 刺突蛋白变体感染中的作用。
PLoS Comput Biol. 2021 Aug 5;17(8):e1009286. doi: 10.1371/journal.pcbi.1009286. eCollection 2021 Aug.
3
Emerging SARS-CoV-2 variants of concern and potential intervention approaches.
In-silico and in-vitro studies to identify potential inhibitors of SARS-CoV-2 spike protein from Omani medicinal plants.
通过计算机模拟和体外研究从阿曼药用植物中鉴定严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的潜在抑制剂。
Heliyon. 2024 Oct 24;10(21):e39649. doi: 10.1016/j.heliyon.2024.e39649. eCollection 2024 Nov 15.
4
Natural products as a source of Coronavirus entry inhibitors.天然产物作为冠状病毒进入抑制剂的来源。
Front Cell Infect Microbiol. 2024 Feb 21;14:1353971. doi: 10.3389/fcimb.2024.1353971. eCollection 2024.
5
COVID-19: A novel holistic systems biology approach to predict its molecular mechanisms (in vitro) and repurpose drugs.COVID-19:一种预测其分子机制(体外)和重新利用药物的新型整体系统生物学方法。
Daru. 2023 Dec;31(2):155-171. doi: 10.1007/s40199-023-00471-1. Epub 2023 Aug 19.
6
Exploring the inhibitory potential of and phytoconstituents against the Spike glycoprotein receptor binding domain of SARS-CoV-2 Delta (B.1.617.2) variant and the main protease (M) as therapeutic candidates, using Molecular docking, DFT, and ADME/Tox studies.利用分子对接、密度泛函理论(DFT)和药物代谢动力学/毒理学(ADME/Tox)研究,探索[具体物质]植物成分对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)Delta(B.1.617.2)变体的刺突糖蛋白受体结合结构域和主要蛋白酶(M)的抑制潜力,以作为治疗候选物。
J Mol Struct. 2022 Sep 5;1263:133032. doi: 10.1016/j.molstruc.2022.133032. Epub 2022 Apr 9.
7
COVID-19 therapy, from lung disease to systemic disorder.新冠病毒疾病治疗:从肺部疾病到全身性疾病
Curr Res Pharmacol Drug Discov. 2022;3:100099. doi: 10.1016/j.crphar.2022.100099. Epub 2022 Apr 1.
关注的新型 SARS-CoV-2 变体和潜在的干预方法。
Crit Care. 2021 Jul 12;25(1):244. doi: 10.1186/s13054-021-03662-x.
4
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.德尔塔变异株对抗体中和的敏感性降低。
Nature. 2021 Aug;596(7871):276-280. doi: 10.1038/s41586-021-03777-9. Epub 2021 Jul 8.
5
Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.利用计算机模拟研究 SARS-CoV-2 RBD 热点突变体与 ACE2 的相互作用,以了解其结合亲和力和稳定性。
Virology. 2021 Sep;561:107-116. doi: 10.1016/j.virol.2021.06.009. Epub 2021 Jun 28.
6
Delta coronavirus variant: scientists brace for impact.德尔塔冠状病毒变种:科学家们严阵以待。
Nature. 2021 Jul;595(7865):17-18. doi: 10.1038/d41586-021-01696-3.
7
SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)突变、疫苗与免疫:关注变异株的影响
Signal Transduct Target Ther. 2021 May 22;6(1):203. doi: 10.1038/s41392-021-00623-2.
8
Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection.作为抗新型冠状病毒肺炎感染潜在抑制剂的植物化学化合物虚拟筛选
Beni Suef Univ J Basic Appl Sci. 2021;10(1):9. doi: 10.1186/s43088-021-00095-x. Epub 2021 Jan 28.
9
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.评估 SARS-CoV-2 刺突突变 D614G 对传染性和致病性的影响。
Cell. 2021 Jan 7;184(1):64-75.e11. doi: 10.1016/j.cell.2020.11.020. Epub 2020 Nov 19.
10
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.SARS-CoV-2 刺突蛋白 D614G 突变增加了病毒粒子刺突密度和感染力。
Nat Commun. 2020 Nov 26;11(1):6013. doi: 10.1038/s41467-020-19808-4.